| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
7.14 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
GRB10 |
IPI00012752 |
7.14 |
Evidence |
|
| PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
7.14 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
DNM1 |
DNM1, DNM: Dynamin-1 |
7.14 |
Evidence |
|
| BCR |
BCR, BCR1, D22S11: Breakpoint cluster region protein |
STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
7.14 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
LOC649805 |
Ig heavy chain V-II region COR |
7.14 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
PRIC285 |
PRIC285, KIAA1769: Peroxisomal proliferator-activated receptor A-interacting com |
7.14 |
Evidence |
|
| NULL |
Ig lambda chain V-I region EPS |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
7.14 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SNX12 |
IPI00438170 |
7.14 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
LOC649805 |
Ig heavy chain V-II region COR |
7.14 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MARK2 |
IPI00555838 |
7.14 |
Evidence |
|
| NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
7.14 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
IGHE |
IGHE: Ig epsilon chain C region |
7.14 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
DNM2 |
DNM2, DYN2: Dynamin-2 |
7.14 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
YLPM1 |
IPI00165434 |
7.14 |
Evidence |
|
| NULL |
TCRA: T-cell receptor alpha chain V region CTL-L17 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
7.14 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PTPRA |
IPI00032333 |
7.14 |
Evidence |
|
| FN1 |
FN1, FN: Fibronectin precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
7.14 |
Evidence |
|
| FGG |
FGG, PRO2061: Fibrinogen gamma chain precursor |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-27 alpha chain precursor |
7.14 |
Evidence |
|
| FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
C6orf21 |
LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G |
7.14 |
Evidence |
|
| FGA |
IPI00021885 |
C6orf21 |
LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G |
7.14 |
Evidence |
|
| HLA-DRA |
HLA-DRA, HLA-DRA1: HLA class II histocompatibility antigen, DR alpha chain precu |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
7.14 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-68 alpha chain precursor |
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
7.14 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-68 alpha chain precursor |
FGA |
IPI00021885 |
7.14 |
Evidence |
|
| IGHA1 |
IPI00719411 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
7.14 |
Evidence |
|